2025 -- H 5854 | |
======== | |
LC001383 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2025 | |
____________ | |
A N A C T | |
RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES | |
| |
Introduced By: Representatives Tanzi, McGaw, Fogarty, Ajello, Kislak, Hull, Morales, | |
Date Introduced: February 28, 2025 | |
Referred To: House Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Chapter 5-19.1 of the General Laws entitled "Pharmacies" is hereby amended |
2 | by adding thereto the following section: |
3 | 5-19.1-37. Tobacco cessation therapy prescriptive authority. |
4 | (a) A pharmacist who is licensed pursuant to this chapter and who meets the requirements |
5 | of this section may prescribe and dispense FDA-approved tobacco cessation drug therapies to a |
6 | qualified patient pursuant to rules and regulations adopted by the board of pharmacy, subject to the |
7 | approval of the director of health in consultation with the director of behavioral healthcare, |
8 | developmental disabilities and hospitals. |
9 | (b) For the purposes of this section, "qualified patient" means a patient who: |
10 | (1) Is at least eighteen (18) years of age or of minimum age based on the most recent |
11 | guidance provided by the FDA; |
12 | (2) Is willing to participate in a structured tobacco cessation program consisting of an initial |
13 | evaluation and appropriate follow-up visits with the pharmacist prescribing tobacco cessation |
14 | products; and |
15 | (3) Has been educated on symptoms of nicotine toxicity, common and/or severe adverse |
16 | effects of prescribed medication(s), and when to seek medical treatment. |
17 | (c) Prior to prescribing tobacco cessation therapies, the pharmacist shall have completed |
18 | tobacco cessation education approved by the state board of pharmacy. |
19 | (d) The pharmacist shall refer or consult prior to prescribing regarding high-risk patients |
| |
1 | or patients with an identified contraindication to FDA-approved tobacco cessation drug therapies |
2 | to the patient's primary care provider, as applicable, or to another provider, as appropriate. |
3 | (e) All pharmacists participating in prescribing therapy for tobacco cessation shall follow |
4 | the most updated guidelines and standards of care as approved by the board of pharmacy, subject |
5 | to the approval of the director of health in consultation with the director of behavioral healthcare, |
6 | developmental disabilities and hospitals. |
7 | (1) Pharmacists shall implement the most updated clinical practice guidelines to help |
8 | patients quit using all forms of tobacco. |
9 | (2) Pharmacists' services shall include an educational component to include counseling on |
10 | medication therapies and cessation strategies as well as referral to sources provided by the |
11 | department of health. |
12 | (f) Notification of the patient screening, the prescription record and the follow-up care plan |
13 | shall be provided to the patient's primary care provider, as applicable, within five (5) business days |
14 | following the prescribing of a tobacco cessation product. |
15 | (g) The definition of a qualified patient is subject to adaptation pursuant to rules and |
16 | regulations adopted by the board of pharmacy, subject to the approval of the director of health in |
17 | consultation with the director of behavioral healthcare, developmental disabilities and hospitals. |
18 | (h) Tobacco cessation drug therapies shall be covered by Medicaid upon approval of the |
19 | Medicaid section 1115 demonstration waiver to be submitted by the secretary of the executive |
20 | office of health and human services pursuant to chapter 12.4 of title 42. |
21 | SECTION 2. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance |
22 | Policies" is hereby amended by adding thereto the following sections: |
23 | 27-18-95. Mandatory coverage for tobacco cessation drug therapies. |
24 | Every group health insurance contract, or medical expense insurance policy, plan or group |
25 | policy delivered, issued for delivery, or renewed in this state, by any health insurance carrier, on or |
26 | after January 1, 2026, shall provide coverage for tobacco cessation drug therapy. |
27 | 27-18-96. Coverage for pharmacists' services. |
28 | (a) Every group health insurance contract, or every group hospital or medical expense |
29 | insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by |
30 | any health insurance carrier, on or after January 1, 2026, shall provide coverage for the services |
31 | within the lawful scope of practice of pharmacists pursuant to § 5-19.1-2 if the plan would have |
32 | provided coverage if the service had been performed by a physician, advanced practice nurse, or |
33 | physician assistant. No nonprofit medical service corporation may require supervision, signature, |
34 | or referral by any other healthcare provider as a condition of reimbursement to a pharmacist; |
| LC001383 - Page 2 of 6 |
1 | provided that, no nonprofit medical service corporation may be required to pay for duplicative |
2 | services actually rendered by both a pharmacist and any other healthcare provider. |
3 | (b) The health plan shall include an adequate number of pharmacists in its network of |
4 | participating medical providers. The participation of pharmacies in the plan network's drug benefit |
5 | does not satisfy the requirement that plans include pharmacists in their networks of participating |
6 | medical providers. |
7 | (c) The healthcare benefits outlined in this section shall apply only to services delivered |
8 | within the health insurer's provider network; provided that, all health insurers shall be required to |
9 | provide coverage for those benefits mandated by this section outside of the health insurer's provider |
10 | network where it can be established that the required services are not available from a provider in |
11 | the health insurer's network. |
12 | SECTION 3. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service |
13 | Corporations" is hereby amended by adding thereto the following sections: |
14 | 27-19-87. Mandatory coverage for tobacco cessation drug therapies. |
15 | Every group health insurance contract, or medical expense insurance policy, plan or group |
16 | policy delivered, issued for delivery, or renewed in this state, by any health insurance carrier, on or |
17 | after January 1, 2026, shall provide coverage for tobacco cessation drug therapy. |
18 | 27-19-88. Coverage for pharmacists' services. |
19 | (a) Every group health insurance contract, or every group hospital or medical expense |
20 | insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by |
21 | any health insurance carrier, on or after January 1, 2026, shall provide coverage for the services |
22 | within the lawful scope of practice of pharmacists pursuant to § 5-19.1-2 if the plan would have |
23 | provided coverage if the service had been performed by a physician, advanced practice nurse, or |
24 | physician assistant. No nonprofit medical service corporation may require supervision, signature, |
25 | or referral by any other healthcare provider as a condition of reimbursement to a pharmacist; |
26 | provided that, no nonprofit medical service corporation may be required to pay for duplicative |
27 | services actually rendered by both a pharmacist and any other healthcare provider. |
28 | (b) The health plan shall include an adequate number of pharmacists in its network of |
29 | participating medical providers. The participation of pharmacies in the plan network's drug benefit |
30 | does not satisfy the requirement that plans include pharmacists in their networks of participating |
31 | medical providers. |
32 | (c) The healthcare benefits outlined in this section shall apply only to services delivered |
33 | within the health insurer's provider network; provided that, all health insurers shall be required to |
34 | provide coverage for those benefits mandated by this section outside of the health insurer's provider |
| LC001383 - Page 3 of 6 |
1 | network where it can be established that the required services are not available from a provider in |
2 | the health insurer's network. |
3 | SECTION 4. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service |
4 | Corporations" is hereby amended by adding thereto the following sections: |
5 | 27-20-83. Mandatory coverage for tobacco cessation drug therapies. |
6 | Every group health insurance contract, or medical expense insurance policy, plan or group |
7 | policy delivered, issued for delivery, or renewed in this state, by any health insurance carrier, on or |
8 | after January 1, 2026, shall provide coverage for tobacco cessation drug therapy. |
9 | 27-20-84. Coverage for pharmacists' services. |
10 | (a) Every group health insurance contract, or every group hospital or medical expense |
11 | insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by |
12 | any health insurance carrier, on or after January 1, 2026, shall provide coverage for the services |
13 | within the lawful scope of practice of pharmacists pursuant to § 5-19.1-2 if the plan would have |
14 | provided coverage if the service had been performed by a physician, advanced practice nurse, or |
15 | physician assistant. No nonprofit medical service corporation may require supervision, signature, |
16 | or referral by any other healthcare provider as a condition of reimbursement to a pharmacist; |
17 | provided that, no nonprofit medical service corporation may be required to pay for duplicative |
18 | services actually rendered by both a pharmacist and any other healthcare provider. |
19 | (b) The health plan shall include an adequate number of pharmacists in its network of |
20 | participating medical providers. The participation of pharmacies in the plan network's drug benefit |
21 | does not satisfy the requirement that plans include pharmacists in their networks of participating |
22 | medical providers. |
23 | (c) The healthcare benefits outlined in this section shall apply only to services delivered |
24 | within the health insurer's provider network; provided that, all health insurers shall be required to |
25 | provide coverage for those benefits mandated by this section outside of the health insurer's provider |
26 | network where it can be established that the required services are not available from a provider in |
27 | the health insurer's network. |
28 | SECTION 5. Chapter 27-41 of the General Laws entitled "Health Maintenance |
29 | Organizations" is hereby amended by adding thereto the following sections: |
30 | 27-41-100. Mandatory coverage for tobacco cessation drug therapies. |
31 | Every group health insurance contract, or medical expense insurance policy, plan or group |
32 | policy delivered, issued for delivery, or renewed in this state, by any health insurance carrier, on or |
33 | after January 1, 2026, shall provide coverage for tobacco cessation drug therapy. |
34 | 27-41-101. Coverage for pharmacists' services. |
| LC001383 - Page 4 of 6 |
1 | (a) Every group health insurance contract, or every group hospital or medical expense |
2 | insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by |
3 | any health insurance carrier, on or after January 1, 2026, shall provide coverage for the services |
4 | within the lawful scope of practice of pharmacists pursuant to § 5-19.1-2 if the plan would have |
5 | provided coverage if the service had been performed by a physician, advanced practice nurse, or |
6 | physician assistant. No nonprofit medical service corporation may require supervision, signature, |
7 | or referral by any other healthcare provider as a condition of reimbursement to a pharmacist; |
8 | provided that, no nonprofit medical service corporation may be required to pay for duplicative |
9 | services actually rendered by both a pharmacist and any other healthcare provider. |
10 | (b) The health plan shall include an adequate number of pharmacists in its network of |
11 | participating medical providers. The participation of pharmacies in the plan network's drug benefit |
12 | does not satisfy the requirement that plans include pharmacists in their networks of participating |
13 | medical providers. |
14 | (c) The healthcare benefits outlined in this section shall apply only to services delivered |
15 | within the health insurer's provider network; provided that, all health insurers shall be required to |
16 | provide coverage for those benefits mandated by this section outside of the health insurer's provider |
17 | network where it can be established that the required services are not available from a provider in |
18 | the health insurer's network. |
19 | SECTION 6. This act shall take effect upon passage. |
======== | |
LC001383 | |
======== | |
| LC001383 - Page 5 of 6 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES | |
*** | |
1 | This act would add new sections which set forth conditions for pharmacists to prescribe |
2 | tobacco cessation drug therapies, including education approved by the state board of pharmacy. |
3 | The cessation therapies would be covered by all health insurance carriers on or after January 1, |
4 | 2026. |
5 | This act would take effect upon passage. |
======== | |
LC001383 | |
======== | |
| LC001383 - Page 6 of 6 |